Effects of DES Platforms on Markers of Endothelial Damage and Inflammation

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

Also called NCT01489202

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose diagnostic
Phase
Phase 4
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT01489202
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Italy (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01489202. Randomized; single masking; primary purpose diagnostic. Start 2014-09 (registry gives no type); primary completion 2015-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Effects of DES Platforms on Markers of Endothelial Damage and Inflammation
Acronym
PLATFORM
Intervention (Device)
platinum chromium everolimus-eluting stent
Intervention (Device)
cobalt chromium everolimus-eluting stent
Lead sponsor
University of Roma La Sapienza (class: other)

Record details

Record id
cardio:ct-nct01489202
Content hash
bc552f1baeaa9ef95c1dd6258e114ca896b1756b62dea93ed792ac8ca8e57fa9